Melax Tech, a world leader in biomedical Natural Language Processing (NLP) Technology, announced a new partnership with the University of California, Irvine (UCI). This partnership will provide UCI researchers the capability to derive insights from EHR notes through our NLP-based LANN and CLAMP products installed on the UCI Health Data Science Platform.
LANN is a team-based text annotation tool that will be used to annotate clinical notes and train NLP models. CLAMP is an NLP development and customization tool to develop hybrid NLP pipelines with machine learning, deep learning, dictionary, and rules for clinical information extraction.
“We are excited to work with the UCI team to help facilitate their NLP research focused on improving patient safety. I am looking forward to working with the UCI research team on more NLP use cases in the future,” says Jingqi Wang, Chief Technology Officer at Melax Tech.
“There has been a strong desire among UCI researchers to have the capability to analyze free-text clinical narrative data using cutting-edge NLP technologies. We are delighted to have this opportunity to work with Melax Tech to deploy their AI-driven annotation and analytics tools to help our researchers advance their research agenda by leveraging the vast amount of free-text data that our health system has accumulated in the past two decades,” says Kai Zheng, Chief Research Information Officer at UCI Health Affairs.